Gainers
- TransMedics Group TMDX stock moved upwards by 10.2% to $71.15 during Wednesday's after-market session. The market value of their outstanding shares is at $2.2 billion. As per the news, the Q4 earnings report came out today.
- AquaBounty Technologies AQB shares rose 6.32% to $0.84. The company's market cap stands at $59.7 million.
- BioVie BIVI stock increased by 5.83% to $5.99. The market value of their outstanding shares is at $209.5 million.
- Infinity Pharmaceuticals INFI stock moved upwards by 5.45% to $0.58. The company's market cap stands at $51.8 million.
- Tivic Health Systems TIVC shares rose 5.02% to $0.23. The market value of their outstanding shares is at $6.8 million.
- Compass Pathways CMPS stock increased by 4.99% to $9.03. The company's market cap stands at $384.4 million.
Losers
- Aprea Therapeutics APRE shares fell 22.4% to $4.9 during Wednesday's after-market session. The market value of their outstanding shares is at $12.9 million.
- Teladoc Health TDOC shares declined by 8.23% to $27.01. At the close, Teladoc Health's trading volume reached 682.4K shares. This is 16.1% of its average volume over the last 100 days. The company's market cap stands at $4.3 billion. As per the press release, Q4 earnings came out today.
- Sorrento Therapeutics SRNE shares decreased by 7.65% to $0.28. This security traded at a volume of 27.3 million shares come close, making up 86.2% of its average volume over the last 100 days. The market value of their outstanding shares is at $155.4 million.
- Immix Biopharma IMMX stock declined by 6.9% to $2.16. The company's market cap stands at $30.0 million.
- Tandem Diabetes Care TNDM shares decreased by 6.37% to $37.5. The market value of their outstanding shares is at $2.4 billion. The company's, Q4 earnings came out today.
- American Well AMWL shares fell 6.08% to $3.4. The company's market cap stands at $936.3 million. As per the press release, Q4 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in